Shechter M - Search Results

1

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. Matetzky S, et al. Among authors: shechter m. Circulation. 2004 Jun 29;109(25):3171-5. doi: 10.1161/01.CIR.0000130846.46168.03. Epub 2004 Jun 7. Circulation. 2004. PMID: 15184279

2

Additional ST segment elevation during the first hour of thrombolytic therapy: an electrocardiographic sign predicting a favorable clinical outcome.

Shechter M, Rabinowitz B, Beker B, Motro M, Barbash G, Kaplinsky E, Hod H. Shechter M, et al. J Am Coll Cardiol. 1992 Dec;20(7):1460-4. doi: 10.1016/0735-1097(92)90437-r. J Am Coll Cardiol. 1992. PMID: 1452918 Free article.

3

Beneficial effect of magnesium sulfate in acute myocardial infarction.

Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am J Cardiol. 1990 Aug 1;66(3):271-4. doi: 10.1016/0002-9149(90)90834-n. Am J Cardiol. 1990. PMID: 2195862 Clinical Trial.

4

Pseudoakinesis: a radionuclide ventriculography sign for subacute heart rupture and tamponade early after acute myocardial infarction.

Leor J, Hod H, Kaplinsky E, Shechter M, Motro M. Leor J, et al. Among authors: shechter m. Am Heart J. 1989 Sep;118(3):612-4. doi: 10.1016/0002-8703(89)90279-2. Am Heart J. 1989. PMID: 2773777 No abstract available.

5

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.

Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am J Cardiol. 1995 Feb 15;75(5):321-3. doi: 10.1016/s0002-9149(99)80546-3. Am J Cardiol. 1995. PMID: 7856520 Clinical Trial.

6

Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. SPRINT Study Group.

Behar S, Reicher-Reiss H, Shechter M, Rabinowitz B, Kaplinsky E, Abinader E, Agmon J, Friedman Y, Barzilai J, Kauli N, et al. Behar S, et al. Among authors: shechter m. Am J Cardiol. 1993 Jan 15;71(2):152-6. doi: 10.1016/0002-9149(93)90730-z. Am J Cardiol. 1993. PMID: 8421975

7

The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy.

Shechter M, Hod H, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am Heart J. 1996 Aug;132(2 Pt 2 Su):483-6; discussion 496-502. doi: 10.1016/s0002-8703(96)90340-3. Am Heart J. 1996. PMID: 8694008 Review.

8

Acute myocardial infarction without thrombolytic therapy: beneficial effects of magnesium sulfate.

Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Shechter M, et al. Herz. 1997 Jun;22 Suppl 1:73-6. doi: 10.1007/BF03042658. Herz. 1997. PMID: 9259191 Clinical Trial.

9

The role of magnesium as antithrombotic therapy.

Shechter M. Shechter M. Wien Med Wochenschr. 2000;150(15-16):343-7. Wien Med Wochenschr. 2000. PMID: 11105330 Review.

10

Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients.

Shechter M, Hod H, Rabinowitz B, Boyko V, Chouraqui P. Shechter M, et al. Cardiology. 2003;99(4):205-10. doi: 10.1159/000071250. Cardiology. 2003. PMID: 12845247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters